Physician profile
Douglas Edgren
NPI 1033145164
$5,003.42
in general payments reported to CMS, 2019-2025
47 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $525 · 2021: $865 · 2022: $1,115 · 2023: $683 · 2024: $685 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $684.82 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Glaxosmithkline, LLC. | $526.73 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.91 | 2019-2025 | Jardiance |
| Amgen INC. | $398.17 | 2019-2025 | Repatha, Otezla, Prolia |
| Vanda Pharmaceuticals INC. | $368.35 | 2022-2023 | Fanapt, Hetlioz |
| Astrazeneca Pharmaceuticals Lp | $303.22 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $221.23 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $185.87 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $153.97 | 2019-2022 | |
| Exact Sciences Corporation | $127.95 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $117.45 | 2019-2025 | |
| Lilly USA, LLC | $105.50 | 2019-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $100.94 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $98.03 | 2019-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.32 | 2020-2023 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Edgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.